Sponsor:
University of New Mexico
Code:
NCT06940609
Conditions
Long COVID
Long COVID Syndrome
Long COVID-19 Syndrome
PASC
PASC Post Acute Sequelae of COVID 19
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
accelerated intermittent theta burst stimulation
Brief summary:
Conditions
Long COVID
Long COVID Syndrome
Long COVID-19 Syndrome
PASC
PASC Post Acute Sequelae of COVID 19
Study ID
NCT06940609
Start date
Jul 7, 2025
Status verified date
Jul, 2026
Completion date
Jun 30, 2029
Anticipated
Primary completion date
Jun 30, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
sham comparator: Sham accelerated iTBS
experimental: Active accelerated iTBS
Interventions
accelerated intermittent theta burst stimulation
Primary outcome measure
Central contacts
Locations
University of New Mexico Health Science Center
Recruiting
Albuquerque, New Mexico, United States, 87106
Contacts
Principal Investigator:
Davin Quinn, MD
Sponsor
University of New Mexico
Last update posted
Jul 15, 2026
Last verified
Jul, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of New Mexico on 2026-07-15.